{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:28:27Z","timestamp":1791332907742,"version":"4.3.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2003,10,23]],"date-time":"2003-10-23T00:00:00Z","timestamp":1066867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2003,10,23]],"date-time":"2003-10-23T00:00:00Z","timestamp":1066867200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2004,1,1]]},"DOI":"10.1038\/sj.leu.2403176","type":"journal-article","created":{"date-parts":[[2003,10,23]],"date-time":"2003-10-23T09:27:04Z","timestamp":1066901224000},"page":"126-132","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":56,"title":["Loss of the ex vivo but not the reinducible CD8+ T-cell response to Tax in human T-cell leukemia virus type 1-infected patients with adult T-cell leukemia\/lymphoma"],"prefix":"10.1038","volume":"18","author":[{"given":"B","family":"Arnulf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Thorel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Poirot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Tamouza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Boulanger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Jaccard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Oksenhendler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O","family":"Hermine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Pique","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2003,10,23]]},"reference":[{"key":"BF2403176_CR1","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1111\/j.1365-2141.1991.tb08051.x","volume":"79","author":"M Shimoyama","year":"1991","unstructured":"Shimoyama M . Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984\u201387). Br J Haematol 1991; 79: 428\u2013437.","journal-title":"Br J Haematol"},{"key":"BF2403176_CR2","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1159\/000150438","volume":"38","author":"K Tajima","year":"1995","unstructured":"Tajima K, Cartier L . Epidemiological features of HTLV-I and adult T cell leukemia. Intervirology 1995; 38: 238\u2013246.","journal-title":"Intervirology"},{"key":"BF2403176_CR3","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1093\/oxfordjournals.aje.a117580","volume":"142","author":"A Kramer","year":"1995","unstructured":"Kramer A, Maloney EM, Morgan OS, Rodgers-Johnson P, Manns A, Murphy EL et al. Risk factors and cofactors for human T-cell lymphotropic virus type I (HTLV-I)-associated myelopathy\/tropical spastic paraparesis (HAM\/TSP) in Jamaica. Am J Epidemiol 1995; 142: 1212\u20131220.","journal-title":"Am J Epidemiol"},{"key":"BF2403176_CR4","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1056\/NEJM199002083220607","volume":"322","author":"O Gout","year":"1990","unstructured":"Gout O, Baulac M, Gessain A, Semah F, Saal F, Peries J et al. Rapid development of myelopathy after HTLV-I infection acquired by transfusion during cardiac transplantation. N Engl J Med 1990; 322: 383\u2013388.","journal-title":"N Engl J Med"},{"key":"BF2403176_CR5","doi-asserted-by":"publisher","first-page":"586","DOI":"10.3109\/13550289809114225","volume":"4","author":"M Nagai","year":"1998","unstructured":"Nagai M, Usuku K, Matsumoto W, Kodama D, Takenouchi N, Moritoyo T et al. Analysis of HTLV-I proviral load in 202 HAM\/TSP patients and 243 asymptomatic HTLV-I carriers: high proviral load strongly predisposes to HAM\/TSP. J Neurovirol 1998; 4: 586\u2013593.","journal-title":"J Neurovirol"},{"key":"BF2403176_CR6","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1086\/317932","volume":"183","author":"M Nagai","year":"2001","unstructured":"Nagai M, Kubota R, Greten TF, Schneck JP, Leist TP, Jacobson S . Increased activated human T cell lymphotropic virus type I (HTLV-I) Tax 11\u201319-specific memory and effector CD8+ cells in patients with HTLV-I-associated myelopathy\/tropical spastic paraparesis: correlation with HTLV-I provirus load. J Infect Dis 2001; 183: 197\u2013205.","journal-title":"J Infect Dis"},{"key":"BF2403176_CR7","doi-asserted-by":"crossref","first-page":"482","DOI":"10.4049\/jimmunol.161.1.482","volume":"161","author":"R Kubota","year":"1998","unstructured":"Kubota R, Kawanishi T, Matsubara H, Manns A, Jacobson S . Demonstration of human T lymphotropic virus type I (HTLV-I) tax-specific CD8+ lymphocytes directly in peripheral blood of HTLV-I-associated myelopathy\/tropical spastic paraparesis patients by intracellular cytokine detection. J Immunol 1998; 161: 482\u2013488.","journal-title":"J Immunol"},{"key":"BF2403176_CR8","doi-asserted-by":"publisher","first-page":"3848","DOI":"10.1073\/pnas.96.7.3848","volume":"96","author":"KJ Jeffery","year":"1999","unstructured":"Jeffery KJ, Usuku K, Hall SE, Matsumoto W, Taylor GP, Procter J et al. HLA alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-I-associated myelopathy. Proc Natl Acad Sci USA 1999; 96: 3848\u20133853.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF2403176_CR9","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1093\/intimm\/3.8.761","volume":"3","author":"M Kannagi","year":"1991","unstructured":"Kannagi M, Harada S, Maruyama I, Inoko H, Igarashi H, Kuwashima G et al. Predominant recognition of human T cell leukemia virus type I (HTLV-I) pX gene products by human CD8+ cytotoxic T cells directed against HTLV-I-infected cells. Int Immunol 1991; 3: 761\u2013767.","journal-title":"Int Immunol"},{"key":"BF2403176_CR10","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1006\/viro.1996.0101","volume":"217","author":"S Daenke","year":"1996","unstructured":"Daenke S, Kermode AG, Hall SE, Taylor G, Weber J, Nightingale S et al. High activated and memory cytotoxic T-cell responses to HTLV-1 in healthy carriers and patients with tropical spastic paraparesis. Virology 1996; 217: 139\u2013146.","journal-title":"Virology"},{"key":"BF2403176_CR11","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.1128\/jvi.68.5.2860-2868.1994","volume":"68","author":"CE Parker","year":"1994","unstructured":"Parker CE, Nightingale S, Taylor GP, Weber J, Bangham CR . Circulating anti-Tax cytotoxic T lymphocytes from human T-cell leukemia virus type I-infected people, with and without tropical spastic paraparesis, recognize multiple epitopes simultaneously. J Virol 1994; 68: 2860\u20132868.","journal-title":"J Virol"},{"key":"BF2403176_CR12","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/0042-6822(92)90517-S","volume":"188","author":"CE Parker","year":"1992","unstructured":"Parker CE, Daenke S, Nightingale S, Bangham CR . Activated, HTLV-1-specific cytotoxic T-lymphocytes are found in healthy seropositives as well as in patients with tropical spastic paraparesis. Virology 1992; 188: 628\u2013636.","journal-title":"Virology"},{"key":"BF2403176_CR13","first-page":"S54","volume":"8","author":"M Kannagi","year":"1994","unstructured":"Kannagi M, Matsushita S, Shida H, Harada S . Cytotoxic T cell response and expression of the target antigen in HTLV-I infection. Leukemia 1994; 8: S54\u201359.","journal-title":"Leukemia"},{"key":"BF2403176_CR14","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1084\/jem.191.3.567","volume":"191","author":"C Pique","year":"2000","unstructured":"Pique C, Ureta-Vidal A, Gessain A, Chancerel B, Gout O, Tamouza R et al. Evidence for the chronic in vivo production of human T cell leukemia virus type I Rof and Tof proteins from cytotoxic T lymphocytes directed against viral peptides. J Exp Med 2000; 191: 567\u2013572.","journal-title":"J Exp Med"},{"key":"BF2403176_CR15","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1182\/blood.V95.4.1386.004k22_1386_1392","volume":"95","author":"E Hanon","year":"2000","unstructured":"Hanon E, Hall S, Taylor GP, Saito M, Davis R, Tanaka Y et al. Abundant tax protein expression in CD4+ T cells infected with human T-cell lymphotropic virus type I (HTLV-I) is prevented by cytotoxic T lymphocytes. Blood 2000; 95: 1386\u20131392.","journal-title":"Blood"},{"key":"BF2403176_CR16","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/S1074-7613(00)00065-0","volume":"13","author":"E Hanon","year":"2000","unstructured":"Hanon E, Stinchcombe JC, Saito M, Asquith BE, Taylor GP, Tanaka Y et al. Fratricide among CD8(+) T lymphocytes naturally infected with human T cell lymphotropic virus type I. Immunity 2000; 13: 657\u2013664.","journal-title":"Immunity"},{"key":"BF2403176_CR17","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/348245a0","volume":"348","author":"S Jacobson","year":"1990","unstructured":"Jacobson S, Shida H, McFarlin DE, Fauci AS, Koenig S . Circulating CD8+ cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease. Nature 1990; 348: 245\u2013248.","journal-title":"Nature"},{"key":"BF2403176_CR18","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/j.1349-7006.1995.tb02983.x","volume":"86","author":"Y Katahira","year":"1995","unstructured":"Katahira Y, Yashiki S, Fujiyoshi T, Nomura K, Tara M, Mori M et al. In vitro induction of cytotoxic T lymphocytes against HTLV-I-infected T-cells from adult T-cell leukemia patients, asymptomatic HTLV-I carriers and seronegative healthy donors. Jpn J Cancer Res 1995; 86: 21\u201327.","journal-title":"Jpn J Cancer Res"},{"key":"BF2403176_CR19","first-page":"317","volume":"43","author":"H Taguchi","year":"1989","unstructured":"Taguchi H, Miyoshi I . Immune suppression in HTLV-I carriers: a predictive sign of adult T-cell leukemia. Acta Med Okayama 1989; 43: 317\u2013321.","journal-title":"Acta Med Okayama"},{"key":"BF2403176_CR20","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1089\/088922201300343735","volume":"17","author":"S Yashiki","year":"2001","unstructured":"Yashiki S, Fujiyoshi T, Arima N, Osame M, Yoshinaga M, Nagata Y et al. HLA-A*26, HLA-B*4002, HLA-B*4006, and HLA-B*4801 alleles predispose to adult T cell leukemia: the limited recognition of HTLV type 1 tax peptide anchor motifs and epitopes to generate anti-HTLV type 1 tax CD8(+) cytotoxic T lymphocytes. AIDS Res Hum Retroviruses 2001; 17: 1047\u20131061.","journal-title":"AIDS Res Hum Retroviruses"},{"key":"BF2403176_CR21","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1182\/blood.V97.4.987","volume":"97","author":"Y Furukawa","year":"2001","unstructured":"Furukawa Y, Kubota R, Tara M, Izumo S, Osame M . Existence of escape mutant in HTLV-I tax during the development of adult T-cell leukemia. Blood 2001; 97: 987\u2013993.","journal-title":"Blood"},{"key":"BF2403176_CR22","doi-asserted-by":"crossref","first-page":"4919","DOI":"10.1128\/jvi.70.8.4919-4926.1996","volume":"70","author":"C Pique","year":"1996","unstructured":"Pique C, Connan F, Levilain JP, Choppin J, Dokhelar MC . Among all human T-cell leukemia virus type 1 proteins, tax, polymerase, and envelope proteins are predicted as preferential targets for the HLA-A2-restricted cytotoxic T-cell response. J Virol 1996; 70: 4919\u20134926.","journal-title":"J Virol"},{"key":"BF2403176_CR23","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/nri778","volume":"2","author":"SM Kaech","year":"2002","unstructured":"Kaech SM, Wherry EJ, Ahmed R . Effector and memory T-cell differentiation: implications for vaccine development. Nat Rev Immunol 2002; 2: 251\u2013262.","journal-title":"Nat Rev Immunol"},{"key":"BF2403176_CR24","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1084\/jem.177.6.1567","volume":"177","author":"I Elovaara","year":"1993","unstructured":"Elovaara I, Koenig S, Brewah AY, Woods RM, Lehky T, Jacobson S . High human T cell lymphotropic virus type 1 (HTLV-1)-specific precursor cytotoxic T lymphocyte frequencies in patients with HTLV-1-associated neurological disease. J Exp Med 1993; 177: 1567\u20131573.","journal-title":"J Exp Med"},{"key":"BF2403176_CR25","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1182\/blood.V88.3.1035.bloodjournal8831035","volume":"88","author":"N Mori","year":"1996","unstructured":"Mori N, Gill PS, Mougdil T, Murakami S, Eto S, Prager D . Interleukin-10 gene expression in adult T-cell leukemia. Blood 1996; 88: 1035\u20131045.","journal-title":"Blood"},{"key":"BF2403176_CR26","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1084\/jem.172.1.121","volume":"172","author":"SJ Kim","year":"1990","unstructured":"Kim SJ, Kehrl JH, Burton J, Tendler CL, Jeang KT, Danielpour D et al. Transactivation of the transforming growth factor beta 1 (TGF-beta 1) gene by human T lymphotropic virus type 1 tax: a potential mechanism for the increased production of TGF-beta 1 in adult T cell leukemia. J Exp Med 1990; 172: 121\u2013129.","journal-title":"J Exp Med"},{"key":"BF2403176_CR27","doi-asserted-by":"publisher","first-page":"3383","DOI":"10.1182\/blood.V99.9.3383","volume":"99","author":"ME El-Sabban","year":"2002","unstructured":"El-Sabban ME, Merhi RA, Haidar HA, Arnulf B, Khoury H, Basbous J et al. Human T-cell lymphotropic virus type 1-transformed cells induce angiogenesis and establish functional gap junctions with endothelial cells. Blood 2002; 99: 3383\u20133389.","journal-title":"Blood"},{"key":"BF2403176_CR28","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1023\/A:1011840918149","volume":"23","author":"S Okazaki","year":"2001","unstructured":"Okazaki S, Moriuchi R, Yosizuka N, Sugahara K, Maeda T, Jinnai I et al. HTLV-1 proviruses encoding non-functional TAX in adult T-cell leukemia. Virus Genes 2001; 23: 123\u2013135.","journal-title":"Virus Genes"},{"key":"BF2403176_CR29","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1002\/ijc.2910540411","volume":"54","author":"M Kannagi","year":"1993","unstructured":"Kannagi M, Matsushita S, Harada S . Expression of the target antigen for cytotoxic T lymphocytes on adult T-cell-leukemia cells. Int J Cancer 1993; 54: 582\u2013588.","journal-title":"Int J Cancer"},{"key":"BF2403176_CR30","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1002\/ijc.2910570525","volume":"57","author":"M Setoyama","year":"1994","unstructured":"Setoyama M, Fujiyoshi T, Mizoguchi S, Katahira Y, Yashiki S, Tara M et al. HTLV-I messenger RNA is expressed in vivo in adult T-cell leukemia\/lymphoma patients: an in situ hybridization study. Int J Cancer 1994; 57: 760\u2013764.","journal-title":"Int J Cancer"},{"key":"BF2403176_CR31","doi-asserted-by":"publisher","first-page":"7010","DOI":"10.1128\/JVI.76.14.7010-7019.2002","volume":"76","author":"T Ohashi","year":"2002","unstructured":"Ohashi T, Hanabuchi S, Suzuki R, Kato H, Masuda T, Kannagi M . Correlation of major histocompatibility complex class I downregulation with resistance of human T-cell leukemia virus type 1-infected T cells to cytotoxic T-lymphocyte killing in a rat model. J Virol 2002; 76: 7010\u20137019.","journal-title":"J Virol"},{"key":"BF2403176_CR32","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1093\/jnci\/93.23.1775","volume":"93","author":"S Hanabuchi","year":"2001","unstructured":"Hanabuchi S, Ohashi T, Koya Y, Kato H, Hasegawa A, Takemura F et al. Regression of human T-cell leukemia virus type I (HTLV-I)-associated lymphomas in a rat model: peptide-induced T-cell immunity. J Natl Cancer Inst 2001; 93: 1775\u20131783.","journal-title":"J Natl Cancer Inst"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/2403176.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2403176","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2403176.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T06:44:49Z","timestamp":1682577889000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/2403176"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,10,23]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004,1,1]]}},"alternative-id":["BF2403176"],"URL":"https:\/\/doi.org\/10.1038\/sj.leu.2403176","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,10,23]]},"assertion":[{"value":"1 July 2003","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2003","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2003","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}